These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 19358054

  • 21. Ovarian molar pregnancy.
    Church E, Hanna L, New F, Uku A, Awad H, Watson AJ.
    J Obstet Gynaecol; 2008 Aug; 28(6):660-1. PubMed ID: 19003680
    [No Abstract] [Full Text] [Related]

  • 22. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR, Hatch KD, Younger JB.
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract] [Full Text] [Related]

  • 23. Is it possible to distinguish between complete and partial hydatidiform mole histologically?
    Angunawela P.
    Ceylon Med J; 1992 Jun; 37(2):40. PubMed ID: 1423747
    [No Abstract] [Full Text] [Related]

  • 24. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 25. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay].
    Hara H, Ban Y, Sato R, Nagakura H, Kushima K, Kaihara M, Matsuzaki H.
    Kaku Igaku; 1988 Jan; 25(1):89-96. PubMed ID: 3373811
    [No Abstract] [Full Text] [Related]

  • 26. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY, Brown JB, Newnam KL.
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [Abstract] [Full Text] [Related]

  • 27. Incomplete mole with a false-low level of human chorionic gonadotropin and hyperthyroidism.
    Henriksen R, Opheim GL, Saltrøe E.
    Acta Obstet Gynecol Scand; 2007 Mar; 86(5):633-5. PubMed ID: 17464597
    [No Abstract] [Full Text] [Related]

  • 28. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
    Lambert-Messerlian G, Pinar H, Rubin LP, De Paepe ME, Tantravahi U, Steinhoff MM, Russell M, Canick JA.
    Pediatr Dev Pathol; 2005 Mar; 8(2):230-4. PubMed ID: 15765203
    [Abstract] [Full Text] [Related]

  • 29. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 30. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone.
    Soules MR, Hughes CL, Garcia JA, Livengood CH, Prystowsky MR, Alexander E.
    Obstet Gynecol; 1980 Jun; 55(6):696-700. PubMed ID: 7383455
    [Abstract] [Full Text] [Related]

  • 31. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 32. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM.
    Obstet Gynecol; 2009 Feb 01; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [Abstract] [Full Text] [Related]

  • 33. [Application of a rapid HCG-RIA technique in clinical obstetric and gynecology practice (author's transl)].
    Xu RQ.
    Zhonghua Fu Chan Ke Za Zhi; 1981 Jan 01; 16(1):29-32. PubMed ID: 7297230
    [No Abstract] [Full Text] [Related]

  • 34. Discordant human chorionic gonadotropin results: causes and solutions.
    Hussa RO, Rinke ML, Schweitzer PG.
    Obstet Gynecol; 1985 Feb 01; 65(2):211-9. PubMed ID: 3969234
    [Abstract] [Full Text] [Related]

  • 35. First-trimester serum levels of the beta-subunit of human chorionic gonadotropin in a tubal molar pregnancy.
    Chase JS, Check JH, Nowroozi K, Wu CH.
    Am J Obstet Gynecol; 1987 Oct 01; 157(4 Pt 1):910. PubMed ID: 2445209
    [Abstract] [Full Text] [Related]

  • 36. Comparative studies on biological, immunological and biochemical properties of various human chorionic gonadotropins in blood. 1.
    Tokura T.
    Acta Obstet Gynaecol Jpn; 1970 Jul 01; 17(3):186-97. PubMed ID: 5468865
    [No Abstract] [Full Text] [Related]

  • 37. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY, Wong LC.
    Chin Med J (Engl); 1999 Mar 01; 112(3):260-3. PubMed ID: 11593563
    [Abstract] [Full Text] [Related]

  • 38. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul 01; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 39. Re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review.
    Çekmez Y, Haberal ET, Ulu İ, Gülşen S.
    BJOG; 2016 Sep 01; 123(10):1706. PubMed ID: 27531332
    [No Abstract] [Full Text] [Related]

  • 40. [Regression of hCG in various types of molar pregnancies--clinical course and prognosis].
    Rob L, Robová H, Pluta M, Kulovaný E, Hrehorcák M, Chmel R, Schlegerová D, Kodet R, Macek M.
    Ceska Gynekol; 2001 Jul 01; 66(4):230-5. PubMed ID: 11569415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.